SCHEDULE 13G
Statement of Beneficial Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001104659-25-040177
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 7.2%
- 2026-11-16 SCHEDULE 13G/A · BALYASNY ASSET MANAGEMENT L.P. 9.99%
- 2026-11-16 SCHEDULE 13G/A · Paradigm BioCapital Advisors LP 0.0%
- 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 6.3%
- 2026-11-13 SCHEDULE 13G/A · Affinity Asset Advisors, LLC 9.8%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…